Rallybio

rallybio.com

Rallybio is a privately-held early-stage biotechnological research and development services intended to transform the lives of patients with a devastating disease. The company's services focus on small molecule and protein-based therapies in the late discovery to early clinical stages of drug development, enabling doctors to identify and accelerate the development of transformative breakthrough therapies for patients with severe and rare disorders.